Integer Holdings Corporation $ITGR Stake Lessened by Sculptor Capital LP

Sculptor Capital LP lessened its stake in Integer Holdings Corporation (NYSE:ITGR) by 99.7% in the first quarter, Holdings Channel reports. The institutional investor owned 28,832 shares of the medical equipment provider’s stock after selling 11,471,168 shares during the quarter. Sculptor Capital LP’s holdings in Integer were worth $3,402,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Congress Asset Management Co. increased its stake in shares of Integer by 4.9% in the first quarter. Congress Asset Management Co. now owns 522,656 shares of the medical equipment provider’s stock worth $61,679,000 after buying an additional 24,306 shares during the last quarter. Driehaus Capital Management LLC increased its stake in Integer by 5.5% during the fourth quarter. Driehaus Capital Management LLC now owns 451,464 shares of the medical equipment provider’s stock valued at $59,828,000 after purchasing an additional 23,706 shares during the last quarter. Northern Trust Corp increased its stake in Integer by 14.2% during the fourth quarter. Northern Trust Corp now owns 422,380 shares of the medical equipment provider’s stock valued at $55,974,000 after purchasing an additional 52,556 shares during the last quarter. Cooke & Bieler LP increased its stake in Integer by 6.3% during the first quarter. Cooke & Bieler LP now owns 317,393 shares of the medical equipment provider’s stock valued at $37,456,000 after purchasing an additional 18,790 shares during the last quarter. Finally, Raymond James Financial Inc. increased its stake in Integer by 6.9% during the first quarter. Raymond James Financial Inc. now owns 307,141 shares of the medical equipment provider’s stock valued at $36,245,000 after purchasing an additional 19,839 shares during the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Stock Performance

ITGR stock opened at $107.58 on Friday. The company has a market capitalization of $3.77 billion, a P/E ratio of 47.39, a PEG ratio of 0.85 and a beta of 1.02. The company has a 50-day simple moving average of $112.71 and a 200 day simple moving average of $118.09. Integer Holdings Corporation has a fifty-two week low of $104.93 and a fifty-two week high of $146.36. The company has a quick ratio of 2.18, a current ratio of 3.41 and a debt-to-equity ratio of 0.72.

Integer (NYSE:ITGR) last posted its quarterly earnings data on Thursday, July 24th. The medical equipment provider reported $1.55 earnings per share for the quarter, missing the consensus estimate of $1.57 by ($0.02). The company had revenue of $476.00 million during the quarter, compared to analyst estimates of $464.37 million. Integer had a return on equity of 12.27% and a net margin of 4.61%.The business’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same period in the previous year, the company earned $1.30 EPS. Integer has set its FY 2025 guidance at 6.250-6.510 EPS. Sell-side analysts predict that Integer Holdings Corporation will post 6.01 earnings per share for the current fiscal year.

Insider Activity

In other Integer news, Director Donald J. Spence sold 14,739 shares of the business’s stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $120.38, for a total value of $1,774,280.82. Following the sale, the director directly owned 18,781 shares in the company, valued at approximately $2,260,856.78. The trade was a 43.97% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Martin C. Maxwell sold 8,720 shares of the business’s stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the sale, the director owned 22,170 shares in the company, valued at approximately $2,672,815.20. This trade represents a 28.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.16% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on ITGR. Wells Fargo & Company lowered their target price on shares of Integer from $152.00 to $132.00 and set an “overweight” rating for the company in a research note on Friday, July 25th. Wall Street Zen upgraded shares of Integer from a “hold” rating to a “buy” rating in a research note on Saturday. Citigroup upgraded shares of Integer from a “hold” rating to a “strong-buy” rating and boosted their target price for the company from $133.00 to $140.00 in a research note on Thursday, May 22nd. Truist Financial lowered their target price on shares of Integer from $145.00 to $137.00 and set a “buy” rating for the company in a research note on Friday, July 25th. Finally, Raymond James Financial reduced their price target on shares of Integer from $150.00 to $143.00 and set an “outperform” rating for the company in a report on Friday, July 25th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Integer presently has a consensus rating of “Buy” and a consensus price target of $140.25.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.